参考文献/References:
[1]Raposo G,Stoorvogel W.Extracellular vesicles: exosomes, microvesicles, and friends[J].J Cell Biol, 2013,200(4): 373-383.
[2]贝毅桦,喻溥蛟,肖俊杰.小囊泡中的大学问——外泌体的前世今[J].自然杂志,2017,39(3):191-198.
[3]Vlassov AV,Magdaleno S,Setterquist R,et al.Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials[J].Biochim Biophys Acta,2012,1820(7):940-948.
[4]Zhao H, Yang L, Baddour J, et al. Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism[J]. Elife,2016,5:e10250.
[5]Liu D,Li C,Trojanowicz B,et al. CD97 promotion of gastric carcinoma lymphatic metastasis is exosome dependent[J]. Gastric Cancer,2016,19(3):754-766.
[6]Solé C,Cortés-Hernández J,Felip ML,et al.miR-29c in urinary exosomes as predictor of early renal fibrosis in lupus nephritis[J].Nephrol Dial Transplant,2015,30(9):1448-1496.
[7]陈伟伟,高润霖,刘力生,等.中国心血管病报告2017概要[J].中国循环杂志,2018,33(1):1-8.
[8]Emanueli C,Shearn AI,Angelini GD,et al.Exosomes and exosomal miRNAs in cardiovascular protection and repair[J].Vascul Pharmacol,2015,71:24-30.
[9]Zheng B, Yin WN, Suzuki T, et al. Exosome-mediated miR-155 transfer from smooth muscle cells to endothelial cells induces endothelial injury and promotes atherosclerosis[J].Mol Ther, 2017,25(6):1279-1294.
[10]Madrigal-Matute J, Lindholt JS, Fernandez-Garcia CE, et al. Galectin-3, a biomarker linking oxidative stress and inflammation with the clinical outcomes of patients with atherothrombosis[J]. J Am Heart Assoc, 2014,3(4). pii: e000785.
[11]中华医学会心血管病学分会,中华心血管病杂志编辑委员会.急性ST段抬高型心肌梗死诊断和治疗指南[J].中华心血管杂志,2015,43(5):380-393.
[12]Tseliou E,Fouad J,Reich H,et al.Fibroblasts rendered antifibrotic, antiapoptotic, and angiogenic by priming with cardiosphere-eerived extracellular membrane vesicles [J]. J Am Coll Cardiol,2015,66(6):599-611.
[13]Katare R,Riu F,Mitchell K,et al.Transplantation of human pericyte progenitor cells improves the repair of infarcted heart through activation of an angiogenic program involving micro-RNA-132[J].Circ Res,2011,109(8):894-906.
[14]Ma T, Chen Y, Chen Y, et al. MicroRNA-132, delivered by mesenchymal stem cell-derived exosomes, promote angiogenesis in myocardial infarction[J]. Stem Cells Int,2018, 2018: 3290372.
[15]Barile L,Lionetti V,Cervio E,et al. Extracellular vesicles from human cardiac progenitor cells inhibit cardiomyocyte apoptosis and improve cardiac function after myocardial infarction[J]. Cardiovasc Res,2014,103(4):530-541.
[16]Zhao W, Zheng XL,Zhao SP. Exosome and its roles in cardiovascular diseases[J].Heart Fail Rev,2015,20(3):337-348.
[17]Tano N,Kim HW,Ashraf M. microRNA-150 regulates mobilization and migration of bone marrow-derived mononuclear cells by targeting Cxcr4 [J]. PLoS One, 2011, 6(10): e23114.
[18]中华医学会心血管病学分会心力衰竭学组,中国医师协会心力衰竭专业委员会,中华心血管病杂志编辑委员会.中国心力衰竭诊断和治疗指南2018[J].中华心血管病杂志,2018,46(10):760-789.
[19]Wang L,Liu J, Xu B, et al. Reduced exosome miR-425 and miR-744 in the plasma represents the progression of fibrosis and heart failure [J].Kaohsiung J Med Sci,2018,34(11):626-633.
[20]Liu X,Tong Z,Chen K,et al. The role of miRNA-132 against apoptosis and oxidative stress in heart failure [J]. Biomed Res Int, 2018,1-8:3452748.
[21]Wei C, Kim IK, Kumar S, et al. NF-kappaB mediated miR-26a regulation in cardiac fibrosis [J]. J Cell Physiol, 2013, 228(7): 1433-1442.
[22]Ibrahim AG,Cheng K,Marbán E. Exosomes as critical agents of cardiac regeneration triggered by cell therapy[J]. Stem Cell Reports,2015,2(5):606-619.
[23]潘益凯,孙喜庆.外泌体来源微小RNA在心血管疾病中作用研究进展[J]. 2018,30(4):469-472.
[24]Fang X,Stroud MJ,Ouyang K,et al.Adipocyte-specific loss of PPAR gamma attenuates cardiac hypertrophy[J].JCI Insight,2016,1(16) : e89908．
[25]Gupta S,Knowlton AA. HSP60 trafficking in adult cardiac myocytes: role of the exosomal pathway [J]. Am J Physiol Heart Circ Physiol, 2007, 292(6): H3052-3056.
[26]Ji Y, Qiu M, Shen Y, et al. MicroRNA-327 regulates cardiac hypertrophy and fibrosis induced by pressure overload [J]. Int J Mol Med, 2018, 41(4): 1909-1916.
[27]国家卫生计生委合理用药专家委员会,中国医师协会高血压专业委员会.高血压合理用药指南(第2版)[J].中国医学前沿杂志,2017,9(7):28-125.
[28]Pironti G, Strachan RT, Abraham D, et al. Circulating Exosomes Induced by Cardiac Pressure Overload Contain Functional Angiotensin II Type 1 Receptors[J].Circulation,2015,131(24): 2120-2130.
[29]Otani K, Yokoya M, Kodama T, et al. Plasma exosomes regulate systemic blood pressure in rats [J]. Biochem Biophys Res Commun, 2018, 503(2): 776-783.
[30]Lee C, Mitsialis SA, Aslam M, et al. Exosomes mediate the cytoprotective action of mesenchymal stromal cells on hypoxia-induced pulmonary hypertension [J]. Circulation, 2012, 126(22): 2601-2611.
[31]赵晓琦,程敏.外泌体相关微小RNA的生物学特性及其在多种心血管疾病中的诊断价值[J].临床心血管病杂志,2015,31(9):924-928.
[32]李福山,房冉,饶琳,等.外泌体在心血管疾病诊疗中的作用研究进展[J].浙 江 大 学 学 报,2018,47(3):320-326.
[33]Cai J, Guan W, Tan X, et al. SRY gene transferred by extracellular vesicles accelerates atherosclerosis by promotion of leucocyte adherence to endothelial cells [J]. Clin Sci (Lond), 2015, 129(3):259-269.
[34]Lakhani HV, Khanal T, Gabi A, et al. Developing a panel of biomarkers and miRNA in patients with myocardial infarction for early intervention strategies of heart failure in West Virginian population [J]. PLoS One, 2018, 13(10): e0205329.
[35]Kuwabara Y, Ono K, Horie T, et al. Increased microRNA-1 and microRNA-133a levels in serum of patients with cardiovascular disease indicate myocardial damage[J]. Circ Cardiovasc Genet, 2011, 4(4): 446-454.
[36]Feng Y,Huang W,Wani M,et al. Ischemic preconditioning potentiates the protective effect of stem cells through secretion of exosomes by targeting Mecp2 via miR-22[J]. PLoS ONE,2014,9(2):e88685.
[37]Lai RC,Arslan F,Lee MM,et al.Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury [J]. Stem Cell Res, 2010, 4(3): 214-222.
[38]Salomon C,Ryan J,Sobrevia L,et al.Exosomal signaling during hypoxia mediates microvascular endothelial cell migration and vasculo-genesis[J]. PLoS One,2013,8(7):e68451.
[39]Zhang CJ,Huang Y,Lu JD,et al.Upregulated microRNA-132 rescues cardiac fibrosis and restores cardiocyte proliferation in dilated cardiomyopathy through the phosphatase and tensin homolog-mediated PI3K/Akt signal transduction pathway[J].J Cell Biochem,2018:1-13.
[40]Gartz M,Darlington A,Afzal MZ,et al.Exosomes exert cardioprotection in dystrophin-deficient cardiomyocytes via ERK1/2-p38/MAPK signaling [J].Sci Rep, 2018,8(1): 16519.
相似文献/References:
[1]白春兰,张军.正五聚蛋白-3:新型心血管病炎性标志物[J].心血管病学进展,2016,(1):87.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.023]
BAI Chunlan,ZHANG Jun.Pentraxin-3: A Novel Inflammation Biomarker for Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2016,(5):87.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.023]
[2]宋菲,综述,俞梦越,等.干细胞来源的外泌体:心肌梗死治疗新启示[J].心血管病学进展,2016,(2):125.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.007]
SONG Fei,YU Mengyue.Exosomes Derived from Stem Cells: Novel Approach in Treatment of
Myocardial Infarction[J].Advances in Cardiovascular Diseases,2016,(5):125.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.007]
[3]姚雯,毛露,孙硕,等.心源性外泌体作为冠心病标志物和新靶点展望[J].心血管病学进展,2019,(6):844.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.002]
YAO Wen,MAO Lu,SUN Shuo,et al.Exogenous Exosome as A New Marker and Target of Coronary Heart Disease[J].Advances in Cardiovascular Diseases,2019,(5):844.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.002]
[4]任茂佳,贺文帅,张琪,等.围绝经期对心血管疾病相关危险因素的影响[J].心血管病学进展,2019,(6):911.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.018]
REN Maojia,HE Wenshuai,ZHANG Qi,et al.Effects of Perimenopause on Cardiovascular Risk Factors[J].Advances in Cardiovascular Diseases,2019,(5):911.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.018]
[5]尹琳 黄从新.JP2蛋白和心血管疾病的研究进展[J].心血管病学进展,2019,(7):1004.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.010]
YIN Lin HUANG Congxin.Research Progress of JP2 Protein and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(5):1004.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.010]
[6]朱峰 汪汉 蔡琳.抗体与心血管疾病[J].心血管病学进展,2019,(7):1007.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.011]
ZHU FengWANG HanCAI Lin.Antibodies and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(5):1007.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.011]
[7]邱明仙 王正龙 许官学.心肌肌球蛋白结合蛋白-C磷酸化与心血管疾病关系的研究进展[J].心血管病学进展,2019,(7):1015.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.013]
QIU MingxianWANG ZhenglongXU Guanxue.Research Progress of the Relationship Between Cardiac Myosin Binding Protein-C and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(5):1015.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.013]
[8]姬楠楠 杨晓静 谢勇.单核细胞/高密度脂蛋白比值与心血管疾病的研究进展[J].心血管病学进展,2019,(7):1019.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.014]
JI Nannan YANG Xiaojing XIE Yong.Monocyte/High-density Lipoprotein Ratio and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(5):1019.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.014]
[9]渠海贤 李涛 程流泉.人工智能在心脏磁共振成像中的应用进展[J].心血管病学进展,2019,(5):659.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.001]
[10]侯冬华 郝丽荣.长正五聚蛋白3在动脉粥样硬化和心血管疾病中作用研究的新进展[J].心血管病学进展,2019,(5):805.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.035]
HOU Donghua H AO Lirong.The Study of Atherosclerosis and Cardiovascular Diseases with Pentapycin 3[J].Advances in Cardiovascular Diseases,2019,(5):805.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.035]
[11]张伟 木胡牙提.外泌体源性miRNAs在心血管疾病中的研究进展[J].心血管病学进展,2020,(2):111.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.002]
Zhang Wei,Muhuyati.Exogenous miRNAs in Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2020,(5):111.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.002]
[12]李一凡 张智伟.巨噬细胞相关的外泌体在心血管疾病中的作用研究进展[J].心血管病学进展,2020,(8):839.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.014]
LI Yifan,ZHANG Zhiwei.Role of Macrophage-Related Exosomes in Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2020,(5):839.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.014]